» Portfolio News

18.07.17

NOXXON issues first Tranche of ODIRNANE Bonds

Read more...

11.07.17

NOXXON Pharma announces Prospectus Publication and Share Transfer to the Public Offering Compartment of the Euronext Growth Market 

Read more...

04.07.17

NOXXON announces first patients treated in phase I/II clinical trial of NOX-A12 combined with KEYTRUDA® in metastatic pancreatic and colorectal cancer

Read more...

16.05.17

NOXXON Pharma announces collaboration with National Center for Tumor Diseases in Heidelberg for NOX-A12/KEYTRUDA® Phase 1/2 combination trial

Read more...

02.05.17

NOXXON PHARMA secures a private placement of €1 million and additional financing of up to €10 million through convertible notes with share subscritpion warrants attached to finance further clinical development of NOX-A12

Read more...